3
2
1

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2025-09-05

A Crucial Step! World's First Successful Gene - Edited Pig Lung Transplant into a Brain - Dead Patient

This achievement not only validates the feasibility of gene - editing technology in xenogeneic lung transplantation but also marks China's shift from a follower to a leader in this field. With further research, xenogeneic lung transplantation may bring new hope to countless patients awaiting organ transplants.

2025-09-05

Global Record! Major Breakthrough in China's Implantable Brain - Computer Interface Technology

Chinese scientists have achieved a major breakthrough in the field of implantable brain - computer interface technology. The Aerospace Information Research Institute of the Chinese Academy of Sciences and the First Affiliated Hospital of Harbin Medical University jointly completed the world's first clinical trial for precise positioning of deep - brain tumor boundaries using an implantable microelectrode array. This technology enables high - precision lesion navigation through microelectrode devices implanted in the brain, marking China's leading position in the international arena of precise neurosurgical treatment.

2025-08-29

Break through the bottleneck! 3D printing + stem cell technology to help nerve regeneration

Spinal cord injury is the "incurable injury" in the global medical community. On August 23, the University of Minnesota team published a major study in "Advanced Medical Materials", which opened a light for this dilemma: using 3D printing technology to build a "smart scaffold" and combined with the neural progenitor cells cultivated by stem cells, it successfully set up a neural pathway in the body of rats with completely broken spinal cord, so that they can restore their walking ability after 12 weeks.

2025-08-21

-196°C Technological Breakthrough: Electrically - Driven Deep - Cryogenic Storage System ushers in a New Era of Biological Sample Storage

The R & D team plans to establish a domestic industrial chain covering storage, transportation, and preparation within three years. This will break the current reliance on imported high - end life - science instruments, accelerate the application of independently developed equipment, and provide strong technological support for the development of China's biotechnology sector.

2025-08-21

New Breakthrough! Milk Transforms into “Living Material” in Seconds, a Novel Biogel is Born

The top - tier international materials journal Matter has published online the groundbreaking research findings of a joint team from Columbia University and the University of Padua. This study is the first to systematically disclose how to utilize bovine - derived extracellular vesicles (EVs) extracted from yogurt whey, a by - product of milk processing, to construct bioactive injectable hydrogels with dynamic cross - linking properties. This innovative technology offers a new paradigm for resolving the dual challenges of “injectability” and “maintenance of biological activity” in the field of tissue engineering.

2025-08-15

Good News! Three Organoid Cryopreservation Technologies of Our Team Accepted for National Patents

In the era of rapid development of organoid research, achieving long - term stable preservation while maintaining biological activity and functional integrity remains a crucial bottleneck restricting the clinical translation of this technology and its application in drug R & D. Recently, three technological inventions by the research team of Yinfeng Low - Temperature Medical Research Center were accepted by the National Intellectual Property Administration. These three technologies focus on the challenges of organoid cryopreservation and cover the key steps in the entire process of organoid vitrification preservation, offering a more efficient and reliable solution for safeguarding biological samples in organoid research.

< 1...101112...28 >